ARCHIVES

DCT Board Approves Recompetition Of Drug Development Contracts

This article is from The Cancer Letter archive.

Vol. 19 No. 26 | June 25, 1993

Download PDF Visit The Full Archive

Related Articles

NCCN Also to Warn Doctors. Amgen’s Pledges to Disclose Future Results.

February 23, 2007

ICF Clement Joins Dynalectron In FCRF

January 9, 1987

Tempero, Johnson Take ASCO Offices

June 6, 2003

Clinical Education Guidelines Proposed

April 4, 1975

NCI, Advisors Concur On Need For New Mechanism To Include Cancer Control, Minority Center Needs

September 21, 1984

NCI Virus Program Has “Important Extension of Virology” as New Approach To Etiology

April 23, 1976